Breakwater Capital Group »

Denali Therapeutics shares owned by Breakwater Capital Group

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Breakwater Capital Group from 13F filings

Historical chart of Breakwater Capital Group investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Breakwater Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Breakwater Capital Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $223k 7.6k 29.13

More positions owned by Breakwater Capital Group

Apple (AAPL)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard World Mega Cap Val Etf (MGV)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Ishares Tr Faln Angls Usd (FALN)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Msci Intl Qualty (IQLT)

View all positions for Breakwater Capital Group

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Vanguard Group
Wellington Management Company
FMR
Capital Research Global Investors
Temasek Holdings
State Street Corporation
Crestline Management
Baker Bros. Advisors
Ubs Global Asset Management Americas
Alliancebernstein
T. Rowe Price Associates
Geode Capital Management
Camber Capital Management

View all funds holding Denali Therapeutics